Cel Sci (CVM) Inventory Average (2011 - 2026)
Cel Sci (CVM) posted Inventory Average of $255955.0 for Q1 2026, down 4.09% sequentially from $266865.0 in Q4 2025, and down 70.68% YoY from $872898.0 in Q1 2025.
Cel Sci (CVM) Inventory Average (2011 - 2026) Analysis & Trends
Cel Sci has reported Inventory Average for 14 years, with the latest figure at $255955.0 in Q1 2026.
- Quarterly Inventory Average fell 70.68% year-over-year to $255955.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $255955.0 (down 70.68% YoY) and the FY2025 annual result came in at $661595.0, down 59.51% from the prior year.
- Inventory Average fell to $255955.0 in Q1 2026 per CVM's latest filing, from $266865.0 in the prior quarter.
- Over five years, Inventory Average peaked at $2.5 million in Q2 2024 and troughed at $255955.0 in Q1 2026.
- A 5-year average of $1.6 million and a median of $1.9 million in 2022 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2022 and 2025: Inventory Average surged 55.96% in 2022, then slumped 77.03% in 2025.
- Over 5 years, Inventory Average stood at $1.9 million in 2022, then grew by 19.34% to $2.3 million in 2023, then plunged by 59.02% to $941506.0 in 2024, then tumbled by 71.66% to $266865.0 in 2025, then retreated by 4.09% to $255955.0 in 2026.
- According to Business Quant data, Inventory Average over the past three periods registered $255955.0, $266865.0, and $410661.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 90.57 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 196.36 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 137.65 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Cel Sci | 2.12 Mn | -4.42 Mn | - | 274,112.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 255,955.00 |
| Dec 31, 2025 | 266,865.00 |
| Sep 30, 2025 | 410,661.00 |
| Jun 30, 2025 | 700,366.00 |
| Mar 31, 2025 | 872,898.00 |
| Dec 31, 2024 | 941,506.00 |
| Sep 30, 2024 | 1.79 Mn |
| Jun 30, 2024 | 2.52 Mn |
| Mar 31, 2024 | 2.42 Mn |
| Dec 31, 2023 | 2.30 Mn |
| Sep 30, 2023 | 2.18 Mn |
| Jun 30, 2023 | 2.00 Mn |
| Mar 31, 2023 | 1.87 Mn |
| Dec 31, 2022 | 1.93 Mn |
| Sep 30, 2022 | 2.09 Mn |
| Jun 30, 2022 | 2.09 Mn |
| Mar 31, 2022 | 2.04 Mn |
| Dec 31, 2021 | 2.04 Mn |
| Sep 30, 2021 | 1.79 Mn |
| Jun 30, 2021 | 1.52 Mn |